Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD), Ares Management (ARES) and Citigroup (C)
There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Skyward Specialty Insurance Group, Inc. (SKWD – Research Report), Ares Management (ARES – Research Report) and Citigroup (C – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Skyward Specialty Insurance Group, Inc. (SKWD)
Piper Sandler analyst Paul Newsome maintained a Buy rating on Skyward Specialty Insurance Group, Inc. today and set a price target of $65.00. The company’s shares closed last Monday at $47.16.
According to TipRanks.com, Newsome is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Skyward Specialty Insurance Group, Inc. with a $69.25 average price target.
See the top stocks recommended by analysts >>
Ares Management (ARES)
RBC Capital analyst Bart Dziarski maintained a Buy rating on Ares Management yesterday and set a price target of $173.00. The company’s shares closed last Monday at $114.57.
According to TipRanks.com, Dziarski is a 2-star analyst with an average return of
Ares Management has an analyst consensus of Strong Buy, with a price target consensus of $180.09, a 49.4% upside from current levels. In a report issued on February 9, Goldman Sachs also maintained a Buy rating on the stock with a $165.00 price target.
Citigroup (C)
In a report released today, Scott Siefers from Piper Sandler maintained a Buy rating on Citigroup, with a price target of $135.00. The company’s shares closed last Monday at $110.75.
According to TipRanks.com, Siefers is a 5-star analyst with an average return of
Citigroup has an analyst consensus of Strong Buy, with a price target consensus of $131.94, which is a 14.4% upside from current levels. In a report issued on February 9, J.P. Morgan also maintained a Buy rating on the stock with a $134.00 price target.
